BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20124139)

  • 1. Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up.
    Wilson DM; Abrams SH; Aye T; Lee PD; Lenders C; Lustig RH; Osganian SV; Feldman HA;
    Arch Pediatr Adolesc Med; 2010 Feb; 164(2):116-23. PubMed ID: 20124139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
    van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
    Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial.
    Yanovski JA; Krakoff J; Salaita CG; McDuffie JR; Kozlosky M; Sebring NG; Reynolds JC; Brady SM; Calis KA
    Diabetes; 2011 Feb; 60(2):477-85. PubMed ID: 21228310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study.
    Wiegand S; l'Allemand D; Hübel H; Krude H; Bürmann M; Martus P; Grüters A; Holl RW
    Eur J Endocrinol; 2010 Oct; 163(4):585-92. PubMed ID: 20639355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
    Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
    Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance.
    Love-Osborne K; Sheeder J; Zeitler P
    J Pediatr; 2008 Jun; 152(6):817-22. PubMed ID: 18492523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
    Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
    JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial.
    Atabek ME; Pirgon O
    J Pediatr Endocrinol Metab; 2008 Apr; 21(4):339-48. PubMed ID: 18556965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METFORMIN: an efficacy, safety and pharmacokinetic study on the short-term and long-term use in obese children and adolescents - study protocol of a randomized controlled study.
    van der Aa MP; Elst MA; van Mil EG; Knibbe CA; van der Vorst MM
    Trials; 2014 Jun; 15():207. PubMed ID: 24899137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin.
    Srinivasan S; Ambler GR; Baur LA; Garnett SP; Tepsa M; Yap F; Ward GM; Cowell CT
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2074-80. PubMed ID: 16595599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
    Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of differential effects of metformin treatment in obese children according to pubertal stage and genetic variations: study protocol for a randomized controlled trial.
    Pastor-Villaescusa B; Caballero-Villarraso J; Cañete MD; Hoyos R; Maldonado J; Bueno G; Leis R; Gil Á; Cañete R; Aguilera CM
    Trials; 2016 Jul; 17(1):323. PubMed ID: 27432166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial.
    Dodd JM; Louise J; Deussen AR; Grivell RM; Dekker G; McPhee AJ; Hague W
    Lancet Diabetes Endocrinol; 2019 Jan; 7(1):15-24. PubMed ID: 30528218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal fat and insulin resistance in obese adolescents.
    Glaser Pediatric Research Network Obesity Study Group
    Obesity (Silver Spring); 2010 Feb; 18(2):402-9. PubMed ID: 19713950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Conjugated Linoleic Acid and Metformin on Insulin Sensitivity in Obese Children: Randomized Clinical Trial.
    Garibay-Nieto N; Queipo-García G; Alvarez F; Bustos M; Villanueva E; Ramírez F; León M; Laresgoiti-Servitje E; Duggirala R; Macías T; Cuevas S; Jalife A; Fonseca-Sánchez M; Serratos F; López-Alvarenga JC
    J Clin Endocrinol Metab; 2017 Jan; 102(1):132-140. PubMed ID: 27778642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.
    Baptista T; Martínez J; Lacruz A; Rangel N; Beaulieu S; Serrano A; Arapé Y; Martinez M; de Mendoza S; Teneud L; Hernández L
    Can J Psychiatry; 2006 Mar; 51(3):192-6. PubMed ID: 16618011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
    Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
    Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin in obese children and adolescents: the MOCA trial.
    Kendall D; Vail A; Amin R; Barrett T; Dimitri P; Ivison F; Kibirige M; Mathew V; Matyka K; McGovern A; Stirling H; Tetlow L; Wales J; Wright N; Clayton P; Hall C
    J Clin Endocrinol Metab; 2013 Jan; 98(1):322-9. PubMed ID: 23175691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.